{
    "id": 27849,
    "fullName": "DHX9 - RAF1",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "DHX9-RAF1 results from the fusion of DHX9 and RAF1, resulting in increased MAPK pathway activation as indicated by increased Erk phosphorylation and elevated colony formation in culture (PMID: 29203461). DHX9-RAF1 has been identified in triple-receptor negative breast cancer (PMID: 29203461).",
            "references": [
                {
                    "id": 11267,
                    "pubMedId": 29203461,
                    "title": "Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29203461"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1660,
        "geneSymbol": "DHX9",
        "terms": [
            "DHX9",
            "DDX9",
            "LKP",
            "NDH2",
            "NDHII",
            "RHA"
        ]
    },
    "variant": "DHX9 - RAF1",
    "createDate": "04/25/2018",
    "updateDate": "04/25/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 5894,
                "geneSymbol": "RAF1",
                "terms": [
                    "RAF1",
                    "c-Raf",
                    "CMD1NN",
                    "CRAF",
                    "NS5",
                    "Raf-1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 13789,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BRCA1-deficient triple-receptor negative breast cancer xenograft models harboring DHX9-RAF1 initially demonstrated slow tumor growth when treated with Mekinist (trametinib), eventually resulting in stable disease, however, after 14 days progression ensued (PMID: 29203461).",
            "molecularProfile": {
                "id": 29428,
                "profileName": "DHX9 - RAF1 BRCA1 loss"
            },
            "therapy": {
                "id": 2,
                "therapyName": "Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "unknown",
            "references": [
                {
                    "id": 11267,
                    "pubMedId": 29203461,
                    "title": "Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29203461"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 13798,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BRCA1-deficient triple-receptor negative breast cancer xenograft models harboring DHX9-RAF1 demonstrated complete tumor regression when treated with the combination therapy of Lynparza (olaparib) and Mekinist (trametinib) (PMID: 29203461).",
            "molecularProfile": {
                "id": 29428,
                "profileName": "DHX9 - RAF1 BRCA1 loss"
            },
            "therapy": {
                "id": 6896,
                "therapyName": "Olaparib + Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 11267,
                    "pubMedId": 29203461,
                    "title": "Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29203461"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13800,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BRCA1-deficient triple-receptor negative breast cancer xenograft models harboring DHX9-RAF1 demonstrated slow tumor regression when treated with Lynparza (olaparib) (PMID: 29203461).",
            "molecularProfile": {
                "id": 29428,
                "profileName": "DHX9 - RAF1 BRCA1 loss"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 60081,
                "name": "triple-receptor negative breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 11267,
                    "pubMedId": 29203461,
                    "title": "Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple-Negative Breast Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29203461"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 29417,
            "profileName": "DHX9 - RAF1",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 29428,
            "profileName": "DHX9 - RAF1 BRCA1 loss",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}